April 6, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement regarding the drugmaker lobby’s campaign to deflect blame for high drug prices:
“This latest campaign is an attempt to deflect blame for high drug prices onto the employers, unions, and insurers that struggle to provide affordable coverage.
It’s a losing strategy to demonize plans that apply savings from rebates and discounts to reduce overall premiums and copays but can’t always afford first-dollar coverage for each new high-priced drug that comes to market.
The messages in these ads conflict with previous statements from the drugmaker lobby that plans routinely “share” discounts and rebates to reduce premiums, deductibles and cost-sharing on prescription drugs.”